FcgammaRIIa mediates C-reactive protein-induced inflammatory responses of human vascular smooth muscle cells by activating NADPH oxidase 4

Cardiovasc Res. 2007 Aug 1;75(3):555-65. doi: 10.1016/j.cardiores.2007.04.027. Epub 2007 May 3.

Abstract

Objectives: We investigated the mechanism by which C-reactive protein (CRP) affects pro-inflammatory activities of vascular smooth muscle cells (VSMCs).

Methods and results: RT-PCR, flow cytometry, and immunoblotting assays consistently showed the expression of FcgammaRIIa by cultured VSMCs isolated from human coronary arteries. Immunofluorescence staining of human coronary artery plaque showed the co-localization of FcgammaRIIa with alpha-actin(+) VSMCs in atheromatous regions. Confocal microscopic image analysis of H(2)DCFDA-labeled cells showed that CRP induced intracellular reactive oxygen species (ROS) generation by FcgammaRIIa(+) HEK293T cells. Moreover, CRP time- and dose-dependently generated ROS in VSMCs through FcgammaRIIa activation. VSMCs mainly express NADPH oxidase 4 isoform (Nox4), the suppression of which using a specific siRNA completely abolished CRP-induced ROS generation by VSMCs. The downregulation of p22(phox), a component of the active Nox4 complex, by transfecting with specific decoy oligomers and functional blocking of FcgammaRIIa not only inhibited the CRP-induced ROS generation but also reduced the degree of AP-1 and NF-kappaB activation, the production of MCP-1, IL-6, and ET-1, and the apoptotic changes of VSMCs in response to CRP.

Conclusions: CRP-induced ROS generation by VSMCs, which requires functional activation of FcgammaRIIa and NADPH oxidase 4, orchestrates pro-inflammatory activities of VSMCs and may eventually promote atherogenesis and plaque rupture.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Antigens, CD / genetics
  • Antigens, CD / physiology*
  • Apoptosis
  • C-Reactive Protein / genetics
  • C-Reactive Protein / metabolism
  • C-Reactive Protein / pharmacology*
  • Cell Line
  • Cells, Cultured
  • Chemokine CCL2 / genetics
  • Coronary Disease / metabolism
  • Coronary Disease / pathology
  • Coronary Vessels
  • Endothelin-1 / genetics
  • Enzyme Activation
  • Flow Cytometry
  • Gene Expression / drug effects
  • Humans
  • Interleukin-6 / genetics
  • Male
  • Membrane Glycoproteins / genetics
  • Microscopy, Confocal
  • Myocytes, Smooth Muscle / chemistry
  • Myocytes, Smooth Muscle / immunology*
  • Myocytes, Smooth Muscle / metabolism
  • NADPH Oxidase 1
  • NADPH Oxidase 2
  • NADPH Oxidase 4
  • NADPH Oxidases / analysis
  • NADPH Oxidases / genetics
  • NADPH Oxidases / metabolism*
  • NF-kappa B / metabolism
  • Reactive Oxygen Species / metabolism
  • Receptors, IgG / genetics
  • Receptors, IgG / physiology*
  • Recombinant Proteins / pharmacology
  • Reverse Transcriptase Polymerase Chain Reaction
  • Transcription Factor AP-1 / metabolism
  • Transcription Factor CHOP / genetics
  • Transfection / methods

Substances

  • Antigens, CD
  • CCL2 protein, human
  • Chemokine CCL2
  • DDIT3 protein, human
  • Endothelin-1
  • Fc gamma receptor IIA
  • Interleukin-6
  • Membrane Glycoproteins
  • NF-kappa B
  • Reactive Oxygen Species
  • Receptors, IgG
  • Recombinant Proteins
  • Transcription Factor AP-1
  • Transcription Factor CHOP
  • C-Reactive Protein
  • CYBB protein, human
  • NADPH Oxidase 1
  • NADPH Oxidase 2
  • NADPH Oxidase 4
  • NADPH Oxidases
  • NOX1 protein, human
  • NOX4 protein, human
  • CYBA protein, human